多糖止血粉与常规内镜治疗对消化性溃疡出血的对比研究
这项前瞻性多中心随机开放标签对照试验在4家转诊机构连续纳入216例因消化性溃疡出血行急诊内镜的患者,比较多糖止血粉(PHP)与常规内镜治疗的疗效。PHP组初始止血92/105例(87.6%),常规组96/111例(86.5%),两组再出血无差异;Forrest IIa亚组常规组初始止血失败率13.6%,PHP组无失败(P=.023)。结论为PHP不劣于常规治疗,可用于消化性溃疡出血的初始内镜治疗,但再出血率需进一步研究确认。
要点
- PHP组初始止血92/105例(87.6%),常规治疗组96/111例(86.5%),两组再出血无差异。
- Forrest IIa亚组常规组初始止血失败率13.6%,PHP组无初始止血失败(P=.023)。
- 大溃疡(≥15 mm)与透析的慢性肾脏病是30天再出血的独立危险因素,PHP未出现相关不良事件。
核心结论
- PHP不劣于常规内镜治疗,可能对消化性溃疡出血的初始内镜治疗有用,但再出血率需进一步研究确认。
研究设计与样本
- 前瞻性多中心、随机、开放标签、对照试验,在4家转诊机构连续纳入因消化性溃疡出血行急诊内镜的患者。
- 2017年7月至2021年5月共纳入216例患者,PHP组105例,对照组111例。
- PHP组先注射稀释肾上腺素再喷洒粉末;常规内镜治疗为注射稀释肾上腺素后行电凝或止血夹。
主要发现
- 初始止血:PHP组92/105例(87.6%),常规治疗组96/111例(86.5%)。
- 两组再出血无差异。
- Forrest IIa亚组中,常规治疗组初始止血失败率为13.6%,PHP组无初始止血失败(P=.023)。
- 大溃疡(≥15 mm)与透析的慢性肾脏病是30天再出血的独立危险因素。
- 未出现与PHP使用相关的不良事件。
关键数值与推荐
- 初始止血率:PHP组87.6%(92/105)vs 常规治疗组86.5%(96/111)。
- Forrest IIa亚组初始止血失败率:常规治疗组13.6% vs PHP组0%(P=.023)。
- 再出血独立危险因素:大溃疡(≥15 mm)与透析的慢性肾脏病(30天再出血)。
临床怎么用
- 原文结论认为PHP不劣于常规治疗,可能对消化性溃疡出血的初始内镜治疗有用。
- 原文指出需进一步研究确认PHP的再出血率。
局限性
- 原文结论指出需进一步研究以确认PHP的再出血率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Hemostatic powders have been clinically used in the treatment of gastrointestinal bleeding. We investigated the non-inferiority of a polysaccharide hemostatic powder (PHP), compared with conventional endoscopic treatments, for peptic ulcer bleeding (PUB). METHODS: This study was a prospective multi-center, randomized, open-label, controlled trial at 4 referral institutions. We consecutively enrolled patients who had undergone emergency endoscopy for PUB. The patients were randomly assigned to either a PHP or conventional treatment group. In the PHP group, diluted epinephrine was injected, and the powder was applied as a spray. Conventional endoscopic treatment included the use of electrical coagulation or hemoclipping after injection of diluted epinephrine. RESULTS: Between July 2017 and May 2021, 216 patients were enrolled in this study (PHP group, 105; control group, 111). Initial hemostasis was achieved in 92 of 105 patients (87.6%) in the PHP group and 96 of 111 patients (86.5%) in the conventional treatment group. Re-bleeding did not differ between the 2 groups. In subgroup analysis, the initial hemostasis failure rate in the conventional treatment group was 13.6% for Forrest IIa cases; however, there was no initial hemostasis failure in the PHP group (P = .023). Large ulcer size (≥15 mm) and chronic kidney disease with dialysis were independent risk factors for re-bleeding at 30 days. No adverse events were associated with PHP use. CONCLUSIONS: PHP is not inferior to conventional treatments and could be useful in initial endoscopic treatment for PUB. Further studies are needed to confirm the re-bleeding rate of PHP. CLINICALTRIALS: gov, Number: NCT02717416).
引用
- Jung DH, Park CH, Choi SI, et al. Comparison of a Polysaccharide Hemostatic Powder and Conventional Therapy for Peptic Ulcer Bleeding. Clin Gastroenterol Hepatol. 2023. PMID: 36906081. doi:10.1016/j.cgh.2023.02.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。